American Portfolios Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-81
| Closed | -$4.83K | – | 3578 |
|
|
2022
Q2 | $4.83K | Sell |
81
-28
| -26% | -$1.67K | ﹤0.01% | 2839 |
|
|
2022
Q1 | $7.92K | Buy |
109
+12
| +12% | +$871 | ﹤0.01% | 2782 |
|
|
2021
Q4 | $8.16K | Buy |
97
+20
| +26% | +$1.68K | ﹤0.01% | 2703 |
|
|
2021
Q3 | $6.95K | Buy |
77
+7
| +10% | +$631 | ﹤0.01% | 2716 |
|
|
2021
Q2 | $6.68K | Buy |
70
+4
| +6% | +$381 | ﹤0.01% | 2692 |
|
|
2021
Q1 | $7.52K | Buy |
66
+32
| +94% | +$3.64K | ﹤0.01% | 2512 |
|
|
2020
Q4 | $4.71K | Buy |
34
+3
| +10% | +$415 | ﹤0.01% | 2436 |
|
|
2020
Q3 | $2.55K | Buy |
+31
| New | +$2.55K | ﹤0.01% | 2514 |
|
|
2019
Q4 | – | Sell |
-472
| Closed | -$20.2K | – | 2911 |
|
|
2019
Q3 | $20.2K | Buy |
472
+9
| +2% | +$385 | ﹤0.01% | 1654 |
|
|
2019
Q2 | $29.4K | Buy |
463
+11
| +2% | +$699 | ﹤0.01% | 1498 |
|
|
2019
Q1 | $31.4K | Sell |
452
-16
| -3% | -$1.11K | ﹤0.01% | 1391 |
|
|
2018
Q4 | $20.3K | Buy |
+468
| New | +$20.3K | ﹤0.01% | 1364 |
|